MariMed (OTCMKTS:MRMD – Get Free Report) and Bio-Rad Laboratories (NYSE:BIO – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings.
Volatility and Risk
MariMed has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.
Institutional & Insider Ownership
0.2% of MariMed shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 19.0% of MariMed shares are owned by company insiders. Comparatively, 30.3% of Bio-Rad Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| MariMed | 0 | 2 | 0 | 0 | 2.00 |
| Bio-Rad Laboratories | 1 | 3 | 1 | 0 | 2.00 |
Bio-Rad Laboratories has a consensus target price of $303.33, suggesting a potential upside of 22.48%. Given Bio-Rad Laboratories’ higher possible upside, analysts plainly believe Bio-Rad Laboratories is more favorable than MariMed.
Earnings and Valuation
This table compares MariMed and Bio-Rad Laboratories”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| MariMed | $159.83 million | 0.17 | -$14.48 million | ($0.03) | -2.22 |
| Bio-Rad Laboratories | $2.58 billion | 2.57 | $759.90 million | $6.07 | 40.80 |
Bio-Rad Laboratories has higher revenue and earnings than MariMed. MariMed is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares MariMed and Bio-Rad Laboratories’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| MariMed | -7.82% | -5.00% | -1.29% |
| Bio-Rad Laboratories | 6.52% | 3.56% | 2.49% |
Summary
Bio-Rad Laboratories beats MariMed on 12 of the 13 factors compared between the two stocks.
About MariMed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
